CRWV Form 4: GC Kristen McVeety exercises options and sells shares under 10b5-1 plan
Rhea-AI Filing Summary
Kristen J. McVeety, General Counsel and Secretary of CoreWeave, Inc. (CRWV), reported multiple transactions on 08/27/2025. She exercised a fully vested stock option to acquire 307,613 Class A shares at $0.55 per share and immediately sold portions of her holdings through a Rule 10b5-1 plan adopted May 28, 2025. The Form 4 discloses six separate sell blocks totaling 352,796 shares sold at weighted-average prices from $92.69 to $97.41, raising proceeds reflected by the reported weighted prices. After these transactions, she beneficially owns 853,207 Class A shares, including 95,000 shares held indirectly in the Jackfruit 2024 GRAT, of which she is sole trustee and beneficiary.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating pre-established, non-discretionary trading
- Option exercise and reported transactions are fully disclosed, including weighted-average price ranges
- Reporting person retains substantial ownership with 853,207 Class A shares after transactions
Negative
- Large volume of shares sold (352,796 shares), which materially reduces direct liquid holdings
- Significant insider monetization through multiple high-value sales at prices up to $97.41
Insights
TL;DR: Insider exercised options and sold substantial stock under a 10b5-1 plan, reducing direct holdings while retaining significant exposure.
The reporting shows a common pattern: exercise of a low-cost option followed by structured sales under a pre-established 10b5-1 plan.
Material points for investors include the scale of sales (352,796 shares) executed across multiple price bands from about $92.69 to $97.41 and the post-transaction beneficial ownership of 853,207 shares. This preserves continued insider alignment while monetizing a portion of equity at market prices.
TL;DR: Transactions comply with Rule 10b5-1 and reflect routine insider liquidity rather than an unexplained disposition.
The filing documents that disposals were effected pursuant to a 10b5-1 plan adopted May 28, 2025, and provides weighted-average price ranges for blocks sold. The report also discloses indirect ownership via a GRAT, an important governance detail about control and beneficiary status. Documentation appears complete and properly reported on Form 4.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 307,613 | $0.00 | -- |
| Exercise | Class A Common Stock | 307,613 | $0.55 | $169K |
| Sale | Class A Common Stock | 56,713 | $93.2003 | $5.29M |
| Sale | Class A Common Stock | 51,586 | $94.081 | $4.85M |
| Sale | Class A Common Stock | 70,522 | $95.2805 | $6.72M |
| Sale | Class A Common Stock | 91,708 | $96.2515 | $8.83M |
| Sale | Class A Common Stock | 41,267 | $96.9195 | $4.00M |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.69 to $93.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 and in footnotes 3 through 6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.69 to $94.68, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.71 to $95.70, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.71 to $96.705, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.71 to $97.41, inclusive. The reported securities are directly held by the Jackfruit 2024 GRAT, of which the reporting person is the sole trustee and beneficiary. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 1, 2025.
